Worth Venture Partners, LLC Esperion Therapeutics, Inc. Put Options Transaction History

Worth Venture Partners, LLC

  • $34.6 Million
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 15, 2019
SELL
$36.99 - $59.11 $181,251 - $289,639
-4,900 Closed
0 $0
Q3 2018

Nov 15, 2018
BUY
$40.74 - $51.41 $199,626 - $251,908
4,900 New
4,900 $13,000
Q2 2018

Aug 13, 2018
SELL
$36.2 - $76.4 $575,580 - $1.21 Million
-15,900 Closed
0 $0
Q1 2018

May 25, 2018
SELL
$65.94 - $80.76 $104 Million - $127 Million
-1,574,100 Reduced 99.0%
15,900 $13,000
Q1 2018

May 11, 2018
BUY
$65.94 - $80.76 $105 Million - $128 Million
1,590,000 New
1,590,000 $13,000

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $155M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email